AMGN Amgen Inc
Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Biotechnology > Biotechnology | NASDAQ, MegaCap | Last Price: 388.16 | 2026-02-27 | Atrp: 2.28
Sat 21 Feb 2026 to Fri 27 Feb 2026: Score -8
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | PEG Ratio | 0.9577 | 1.1488 | ▲ 19.95% | Bearish. Lower is better. Moderate increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 13.7363 | 17.0068 | ▲ 23.81% | Bearish. Lower is better. Significant decline Stock price divided by expected future earnings |
| â | Short Percent | 2.47% | 2.69% | ▲ 8.91% | Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Price Sales TTM | 5.4969 | 5.5641 | ▲ 1.22% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 23.3795 | 23.618 | ▲ 1.02% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Short Ratio | 5.06 | 4.67 | ▼ -7.71% | Bullish. Lower is better. Slight improvement |
Sat 14 Feb 2026 to Sat 21 Feb 2026: Score 9
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Enterprise Value/EBITDA | 20.7021 | 14.6701 | ▼ -29.14% | Bullish. Lower is better. Significant improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | PEG Ratio | 1.1267 | 0.9577 | ▼ -15% | Bullish. Lower is better. Moderate decrease, improving the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 16.6667 | 13.7363 | ▼ -17.58% | Bullish. Lower is better. Moderate improvement Stock price divided by expected future earnings |
| â | Operating Margin TTM | 28.22% | 30.55% | ▲ 8.26% | Bullish. Higher is better. Operating margin TTM growth accelerating. Percentage of revenue left after operating expenses |
| â | Wall Street Target Price | 345.5556 | 350.0357 | ▲ 1.3% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | Enterprise Value | $242.86B | $247.89B | ▲ 2.07% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | EBITDA | $17064M | $16617M | ▼ -2.62% | Bearish. Higher is better. Decline in earnings before interest, taxes, depreciation, and amortization; indicates weaker operational cash flow Earnings before interest, taxes, depreciation, and amortization |
| â | Return On Assets TTM | 8.15% | 7.93% | ▼ -2.7% | Bearish. Higher is better. Return on assets TTM growth slowing. Efficiency in generating profits from total assets |
| â | Price Sales TTM | 5.4146 | 5.4969 | ▲ 1.52% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 22.7976 | 23.3795 | ▲ 2.55% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 6.6082 | 6.7453 | ▲ 2.07% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
Sat 07 Feb 2026 to Sat 14 Feb 2026: Score 5
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Percent | 2.6% | 2.47% | ▼ -5% | Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | PEG Ratio | 1.1601 | 1.1267 | ▼ -2.88% | Bullish. Lower is better. Slight decrease, improving the value relative to growth P/E ratio adjusted for growth rate |
| â | Wall Street Target Price | 341.9259 | 345.5556 | ▲ 1.06% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | Price Sales TTM | 5.6365 | 5.4146 | ▼ -3.94% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
Sat 31 Jan 2026 to Sat 07 Feb 2026: Score 1
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Quarterly Earnings Growth YOY | 141% | 1121% | ▲ 720.59% | Bullish. Higher is better. Quarterly earnings growth YOY growth accelerating. Year-over-year growth in quarterly earnings |
| â | Return On Equity TTM | 81.71% | 106.1% | ▲ 29.85% | Bullish. Higher is better. Return on equity TTM growth accelerating. Efficiency in generating profits from shareholders' equity |
| â | Earnings Per Share | 12.89 | 14.22 | ▲ 10.32% | Bullish. Higher is better. Moderate increase in earnings per share Profit allocated to each outstanding share |
| â | EPS Estimate Current Year | 21.2854 | 22.3756 | ▲ 5.12% | Bullish. Higher is better. Slight increase; improved outlook for current year earnings Expected earnings per share this year |
| â | EPS Estimate Next Year | 22.1195 | 23.1465 | ▲ 4.64% | Bullish. Higher is better. Slight raised expectations for further out Expected earnings per share next year |
| â | Profit Margin | 19.47% | 20.98% | ▲ 7.76% | Bullish. Higher is better. Profit margin growth accelerating. Percentage of revenue that turns into profit |
| â | Return On Assets TTM | 7.71% | 8.15% | ▲ 5.71% | Bullish. Higher is better. Return on assets TTM growth accelerating. Efficiency in generating profits from total assets |
| â | Enterprise Value | $229.81B | $243.72B | ▲ 6.05% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | EBITDA | $16481M | $17064M | ▲ 3.54% | Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow Earnings before interest, taxes, depreciation, and amortization |
| â | Wall Street Target Price | 332.7037 | 341.9259 | ▲ 2.77% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
| â | Gross Profit TTM | $25198M | $26014M | ▲ 3.24% | Bullish. Higher is better. Slight increase, but margins may be improving Revenue minus cost of goods sold over the trailing twelve months |
| â | Revenue TTM | $35971M | $36751M | ▲ 2.17% | Bullish. Higher is better. Slight top-line expansion Total revenue over the trailing twelve months |
| â | Revenue Per Share TTM | 66.892 | 68.31 | ▲ 2.12% | Bullish. Higher is better. Slight improvement Revenue generated per outstanding share over the trailing twelve months |
| â | Price Book MRQ | 21.5548 | 22.8972 | ▲ 6.23% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | PEG Ratio | 0.9577 | 1.1601 | ▲ 21.13% | Bearish. Lower is better. Significant increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Book Value | 17.863 | 16.063 | ▼ -10.08% | Bearish. Higher is better. Moderate decrease; stock now trades further from book value Net asset value of the company per share |
| â | Operating Margin TTM | 34.15% | 28.22% | ▼ -17.36% | Bearish. Higher is better. Operating margin TTM growth slowing. Percentage of revenue left after operating expenses |
| â | Forward PE | 13.7363 | 16.7504 | ▲ 21.94% | Bearish. Lower is better. Significant decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 5.1179 | 5.6365 | ▲ 10.13% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value/Revenue | 5.9651 | 6.6316 | ▲ 11.17% | Bearish. Lower is better. Moderate decline Enterprise value divided by revenue |
| â | Quarterly Revenue Growth YOY | 121% | 91% | ▼ -30.65% | Bearish. Higher is better. Quarterly revenue growth YOY growth slowing. Year-over-year growth in quarterly revenue |
| â | Enterprise Value/EBITDA | 13.112 | 20.7757 | ▲ 58.45% | Bearish. Lower is better. Substantial decline Enterprise value to earnings before interest, taxes, depreciation |
Sat 24 Jan 2026 to Sat 31 Jan 2026: Score 9
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | PEG Ratio | 1.0776 | 0.9577 | ▼ -11.13% | Bullish. Lower is better. Moderate decrease, improving the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 15.5763 | 13.7363 | ▼ -11.81% | Bullish. Lower is better. Moderate improvement Stock price divided by expected future earnings |
| â | Enterprise Value/Revenue | 6.4158 | 5.9651 | ▼ -7.02% | Bullish. Lower is better. Slight improvement Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 13.9657 | 13.112 | ▼ -6.11% | Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Short Percent | 2.79% | 2.6% | ▼ -6.81% | Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Price Book MRQ | 19.2994 | 21.5548 | ▲ 11.69% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
Sat 17 Jan 2026 to Sat 24 Jan 2026: Score -7
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Price Sales TTM | 4.9462 | 5.1609 | ▲ 4.34% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 18.4967 | 19.2994 | ▲ 4.34% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | PEG Ratio | 1.0388 | 1.0776 | ▲ 3.74% | Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Forward PE | 15.015 | 15.5763 | ▲ 3.74% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Enterprise Value/Revenue | 6.2011 | 6.4158 | ▲ 3.46% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 13.4984 | 13.9657 | ▲ 3.46% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Enterprise Value | $223.06B | $230.78B | ▲ 3.46% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sat 10 Jan 2026 to Sat 17 Jan 2026: Score -5
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 4.87 | 5.13 | ▲ 5.34% | Bearish. Lower is better. Slight decline |
| â | Short Percent | 2.63% | 2.79% | ▲ 6.08% | Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Price Sales TTM | 4.8817 | 4.9462 | ▲ 1.32% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
Sun 21 Dec 2025 to Sat 03 Jan 2026: Score 1
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Percent | 2.67% | 2.63% | ▼ -1.5% | Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |